Cargando…

P1103: OBINUTUZUMAB INDUCTION AND MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINAEMIA

Detalles Bibliográficos
Autores principales:	Wróbel, Tomasz, Kalicinska, Elzbieta, Maciej Zaucha, Jan, Morawska, Marta, Giannopoulos, Krzysztof, Jamroziak, Krzysztof, Lech-Marańda, Ewa, Taszner, Michał, Szeremet, Agnieszka, Małcecki, Bartosz, Łojko-Dankowska, Anna, Dytfeld, Dominik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430969/ http://dx.doi.org/10.1097/01.HS9.0000971308.43395.98

Ejemplares similares

Cutaneous Involvement in Waldenström’s Macroglobulinaemia
por: STIEN, Sarah, et al.
Publicado: (2020)

Waldenström macroglobulinaemia presenting as tingling ulcers on the feet
por: Fischer, Isabelle, et al.
Publicado: (2013)

Zanubrutinib for mantle cell lymphoma, Waldenström’s macroglobulinaemia
Publicado: (2021)

CANOMAD unmasked by COVID‐19 in a man with Waldenström's macroglobulinaemia
por: Morrison, Hamish D., et al.
Publicado: (2021)

Essential Thrombocythaemia with Concomitant Waldenström Macroglobulinaemia: Case Report and Literature Review
por: Lu, Nina, et al.
Publicado: (2020)

Conditional relative survival in Waldenström’s macroglobulinaemia: a population‐based study in The Netherlands
por: Amaador, Karima, et al.
Publicado: (2021)

Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia
por: Puła, Bartosz, et al.
Publicado: (2022)

Rare presentation of Waldenström’s macroglobulinaemia requiring bilateral above-knee amputations: a case report
por: Deen, Raeed, et al.
Publicado: (2022)

Immune response to COVID‐19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapy
por: Rankin, Katherine, et al.
Publicado: (2023)

Systematic literature review of quality‐of‐life questionnaires in Waldenström macroglobulinaemia—need for a disease‐specific tool
por: Bristogiannis, Sotirios, et al.
Publicado: (2023)

Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis
por: Chan, Wee-Lee, et al.
Publicado: (2023)

Rare lymphomas in routine practice—Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms
por: Knauf, Wolfgang, et al.
Publicado: (2020)

Second malignancies after autologous haematopoietic stem cell transplantation following modified BEAM conditioning regimen in patients with Hodgkin lymphoma – characteristics and risk factor analysis
por: Czyż, Anna, et al.
Publicado: (2013)

Immunophenotypic Characteristics of Bone Marrow Microenvironment Cellular Composition at the Biochemical Progression of Multiple Myeloma
por: Krzywdzińska, Agnieszka, et al.
Publicado: (2022)

Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population‐based study in the Netherlands, 1989–2018
por: Amaador, Karima, et al.
Publicado: (2021)

Patient reported outcome measures in Waldenström macroglobulinaemia: A real‐world data analysis from the WMUK Rory Morrison Registry
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

A Stepwise Screening Protocol for Multiple Myeloma
por: Morawska, Marta, et al.
Publicado: (2023)

With M-protein positive, could transthyretin amyloidosis be easily excluded? Not necessarily! Wild-type transthyretin amyloidosis with Waldenström’s macroglobulinaemia: a case report
por: Kinoshita, Haruyuki, et al.
Publicado: (2022)

Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy
por: Dytfeld, Dominik, et al.
Publicado: (2016)

P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS
por: Uppal, E., et al.
Publicado: (2022)

Bortezomib‐based therapy is effective and well tolerated in frontline and multiply pre‐treated Waldenström macroglobulinaemia including BTKi failures: A real‐world analysis
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience
por: Czyz, Anna, et al.
Publicado: (2013)

Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia
por: Moreno, David F., et al.
Publicado: (2022)

PB1915: THE MULTI-FACETED ROLE OF ORAL AND GUT MICROBIOME IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
por: Paziewska, Magdalena, et al.
Publicado: (2023)

P1149: THE EVOLVING STATE OF PLAY IN 1000 PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINAEMIA IN THE UNITED KINGDOM (UK): A REAL-WORLD DATA ANALYSIS FROM THE WMUK RORY MORRISON REGISTRY PROJECT
por: Uppal, E., et al.
Publicado: (2022)

Edition Eulenburg No. 1103 Overture O.P 362 : Strauss

Late Epstein-Barr virus-related post-transplant lymphoproliferative disorder with intestinal involvement in patient with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: HJELLBAKK, HEDDA KLOSTER, et al.
Publicado: (2020)

Advances in diagnostics and therapy of systemic amyloidoses
por: Jamroziak, Krzysztof, et al.
Publicado: (2020)

Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group
por: Soboń, Anita, et al.
Publicado: (2023)

Multisystem Inflammatory Syndrome in Adults (MIS-A) Reported in Patient with Hematological Malignancy: A Case Report
por: Kalicińska, Elżbieta, et al.
Publicado: (2023)

Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia—A Multicenter Report by the Polish Lymphoma Research Group
por: Drozd-Sokołowska, Joanna, et al.
Publicado: (2022)

1103. Improving Perioperative Prophylactic Antimicrobial Guideline Concordance in Liver and Lung Transplant Recipients
por: Nguyen, Cynthia T, et al.
Publicado: (2019)

Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study
por: Kalicińska, Elżbieta, et al.
Publicado: (2021)

1103. Respiratory Virus Infections In Solid Organ Transplant Recipients: A Single Center Experience
por: Mendoza, Maria A, et al.
Publicado: (2020)

1103. Endemic Coronavirus Infections in a US Cohort of Children from Birth to 4 Years
por: Payne, Daniel C, et al.
Publicado: (2023)

Overcoming Ibrutinib Resistance in Chronic Lymphocytic Leukemia
por: Puła, Bartosz, et al.
Publicado: (2019)

Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit – High mortality rate in infected patients with haematologic malignancies
por: Biernat, Monika M, et al.
Publicado: (2020)

Epidermal barrier function in patients after allogeneic hematopoietic stem cell transplantation – a pilot study
por: Polańska, Adriana, et al.
Publicado: (2022)

Disseminated Enteroviral Infection Associated with Obinutuzumab
por: Dendle, Claire, et al.
Publicado: (2015)

Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation
por: Porrini, Vanessa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fmcnbdsu02girhlpb5hfpvmtkq